Found: 58
Select item for more details and to access through your institution.
Nutritional counseling improves mortality and prevents hepatic encephalopathy in patients with alcohol‐associated liver disease.
- Published in:
- Hepatology Research, 2024, v. 54, n. 11, p. 1089, doi. 10.1111/hepr.14053
- By:
- Publication type:
- Article
Hepatocellular carcinoma patients with increased oxidative stress levels are prone to recurrence after curative treatment: a prospective case series study using the d-ROM test.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 5, p. 845, doi. 10.1007/s00432-013-1389-1
- By:
- Publication type:
- Article
Homeostatic Model Assessment of Insulin Resistance for Predicting the Recurrence of Hepatocellular Carcinoma after Curative Treatment.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 3, p. 605, doi. 10.3390/ijms20030605
- By:
- Publication type:
- Article
Skeletal Muscle Depletion Predicts the Prognosis of Patients with Hepatocellular Carcinoma Treated with Sorafenib.
- Published in:
- International Journal of Molecular Sciences, 2015, v. 16, n. 5, p. 9612, doi. 10.3390/ijms16059612
- By:
- Publication type:
- Article
Impact of Serum Chemerin Levels on Liver Functional Reserves and Platelet Counts in Patients with Hepatocellular Carcinoma.
- Published in:
- International Journal of Molecular Sciences, 2014, v. 15, n. 7, p. 11294, doi. 10.3390/ijms150711294
- By:
- Publication type:
- Article
Late Evening Snack with Branched-Chain Amino Acids Supplementation Improves Survival in Patients with Cirrhosis.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 4, p. 1013, doi. 10.3390/jcm9041013
- By:
- Publication type:
- Article
Unresectable Combined Hepatocellular-cholangiocarcinoma Treated with Combination Therapy Consisting of Durvalumab Plus Tremelimumab.
- Published in:
- Internal Medicine, 2024, v. 63, n. 19, p. 2631, doi. 10.2169/internalmedicine.3071-23
- By:
- Publication type:
- Article
A case of A20 haploinsufficiency complicated by autoimmune hepatitis.
- Published in:
- Hepatology Research, 2024, v. 54, n. 6, p. 606, doi. 10.1111/hepr.14003
- By:
- Publication type:
- Article
Usefulness of the Global Leadership Initiative on Malnutrition criteria to predict sarcopenia and mortality in patients with chronic liver disease.
- Published in:
- Hepatology Research, 2022, v. 52, n. 11, p. 928, doi. 10.1111/hepr.13816
- By:
- Publication type:
- Article
Zinc deficiency predicts overt hepatic encephalopathy and mortality in liver cirrhosis patients with minimal hepatic encephalopathy.
- Published in:
- Hepatology Research, 2021, v. 51, n. 6, p. 662, doi. 10.1111/hepr.13601
- By:
- Publication type:
- Article
Reduced handgrip strength is predictive of poor survival among patients with liver cirrhosis: A sex‐stratified analysis.
- Published in:
- Hepatology Research, 2019, v. 49, n. 12, p. 1414, doi. 10.1111/hepr.13420
- By:
- Publication type:
- Article
Effect of loop diuretics on skeletal muscle depletion in patients with liver cirrhosis.
- Published in:
- Hepatology Research, 2019, v. 49, n. 1, p. 82, doi. 10.1111/hepr.13244
- By:
- Publication type:
- Article
Sarcopenia predicts minimal hepatic encephalopathy in patients with liver cirrhosis.
- Published in:
- Hepatology Research, 2017, v. 47, n. 13, p. 1359, doi. 10.1111/hepr.12873
- By:
- Publication type:
- Article
Rapid skeletal muscle wasting predicts worse survival in patients with liver cirrhosis.
- Published in:
- Hepatology Research, 2016, v. 46, n. 8, p. 743, doi. 10.1111/hepr.12616
- By:
- Publication type:
- Article
Impact of serum glycosylated Wisteria floribunda agglutinin positive Mac-2 binding protein levels on liver functional reserves and mortality in patients with liver cirrhosis.
- Published in:
- Hepatology Research, 2015, v. 45, n. 11, p. 1083, doi. 10.1111/hepr.12473
- By:
- Publication type:
- Article
Efficacy and safety of cisplatin versus miriplatin in transcatheter arterial chemoembolization and transarterial infusion chemotherapy for hepatocellular carcinoma: A randomized controlled trial.
- Published in:
- Hepatology Research, 2015, v. 45, n. 5, p. 514, doi. 10.1111/hepr.12376
- By:
- Publication type:
- Article
Free fatty acid as a marker of energy malnutrition in liver cirrhosis.
- Published in:
- Hepatology Research, 2014, v. 44, n. 2, p. 218, doi. 10.1111/hepr.12112
- By:
- Publication type:
- Article
Combination of acyclic retinoid with branched-chain amino acids inhibits xenograft growth of human hepatoma cells in nude mice.
- Published in:
- Hepatology Research, 2012, v. 42, n. 12, p. 1241, doi. 10.1111/j.1872-034X.2012.01045.x
- By:
- Publication type:
- Article
Insulin resistance raises the risk for recurrence of stage I hepatocellular carcinoma after curative radiofrequency ablation in hepatitis C virus-positive patients: A prospective, case series study.
- Published in:
- Hepatology Research, 2010, v. 40, n. 4, p. 376, doi. 10.1111/j.1872-034X.2009.00616.x
- By:
- Publication type:
- Article
Association between Body Composition and the Risk of Portopulmonary Hypertension Assessed by Computed Tomography in Patients with Liver Cirrhosis.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 10, p. 3351, doi. 10.3390/jcm12103351
- By:
- Publication type:
- Article
Effect of Selenium Deficiency on the Development of Overt Hepatic Encephalopathy in Patients with Chronic Liver Disease.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 8, p. 2869, doi. 10.3390/jcm12082869
- By:
- Publication type:
- Article
Effects of Rifaximin on Circulating Albumin Structures and Serum Ammonia Levels in Patients with Liver Cirrhosis: A Preliminary Study.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 24, p. 7318, doi. 10.3390/jcm11247318
- By:
- Publication type:
- Article
Usefulness of the Trabecular Bone Score in Assessing the Risk of Vertebral Fractures in Patients with Cirrhosis.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 6, p. 1562, doi. 10.3390/jcm11061562
- By:
- Publication type:
- Article
Adverse Events in Targeted Therapy for Unresectable Hepatocellular Carcinoma Predict Clinical Outcomes.
- Published in:
- Cancers, 2024, v. 16, n. 18, p. 3150, doi. 10.3390/cancers16183150
- By:
- Publication type:
- Article
Lenvatinib Exacerbates the Decrease in Skeletal Muscle Mass in Patients with Hepatocellular Carcinoma, Whereas Atezolizumab Plus Bevacizumab Does Not.
- Published in:
- Cancers, 2024, v. 16, n. 2, p. 442, doi. 10.3390/cancers16020442
- By:
- Publication type:
- Article
Lenvatinib or Sorafenib Treatment Causing a Decrease in Skeletal Muscle Mass, an Independent Prognostic Factor in Hepatocellular Carcinoma: A Survival Analysis Using Time-Varying Covariates.
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4223, doi. 10.3390/cancers15174223
- By:
- Publication type:
- Article
Changes in ALBI Score and PIVKA-II within Three Months after Commencing Atezolizumab Plus Bevacizumab Treatment Affect Overall Survival in Patients with Unresectable Hepatocellular Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 24, p. 6089, doi. 10.3390/cancers14246089
- By:
- Publication type:
- Article
Higher Accumulation of Visceral Adipose Tissue Is an Independent Risk Factor for Hepatocellular Carcinoma among Viral Hepatitis Patients with Non-Cirrhotic Livers.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 5980, doi. 10.3390/cancers13235980
- By:
- Publication type:
- Article
Increased Visceral Adipose Tissue and Hyperinsulinemia Raise the Risk for Recurrence of Non-B Non-C Hepatocellular Carcinoma after Curative Treatment.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1542, doi. 10.3390/cancers13071542
- By:
- Publication type:
- Article
Rapid Depletion of Subcutaneous Adipose Tissue during Sorafenib Treatment Predicts Poor Survival in Patients with Hepatocellular Carcinoma.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1795, doi. 10.3390/cancers12071795
- By:
- Publication type:
- Article
Rapid Depletions of Subcutaneous Fat Mass and Skeletal Muscle Mass Predict Worse Survival in Patients with Hepatocellular Carcinoma Treated with Sorafenib.
- Published in:
- Cancers, 2019, v. 11, n. 8, p. 1206, doi. 10.3390/cancers11081206
- By:
- Publication type:
- Article
Survival benefit of l‐carnitine supplementation in patients with cirrhosis.
- Published in:
- JPEN Journal of Parenteral & Enteral Nutrition, 2022, v. 46, n. 6, p. 1326, doi. 10.1002/jpen.2386
- By:
- Publication type:
- Article
Handgrip strength stratifies the risk of covert and overt hepatic encephalopathy in patients with cirrhosis.
- Published in:
- JPEN Journal of Parenteral & Enteral Nutrition, 2022, v. 46, n. 4, p. 858, doi. 10.1002/jpen.2222
- By:
- Publication type:
- Article
Serum MYCN as a predictive biomarker of prognosis and therapeutic response in the prevention of hepatocellular carcinoma recurrence.
- Published in:
- International Journal of Cancer, 2024, v. 155, n. 3, p. 582, doi. 10.1002/ijc.34893
- By:
- Publication type:
- Article
Preventive effects of branched-chain amino acid supplementation on the spontaneous development of hepatic preneoplastic lesions in C57BL/KsJ-db/db obese mice.
- Published in:
- Carcinogenesis, 2012, v. 33, n. 12, p. 2499, doi. 10.1093/carcin/bgs303
- By:
- Publication type:
- Article
Acyclic retinoid in chemoprevention of hepatocellular carcinoma: Targeting phosphorylated retinoid X receptor-α for prevention of liver carcinogenesis.
- Published in:
- Journal of Carcinogenesis, 2012, v. 11, n. 1, p. 1, doi. 10.4103/1477-3163.100398
- By:
- Publication type:
- Article
Sustained Virological Response Is the Most Effective in Preventing Hepatocellular Carcinoma Recurrence after Curative Treatment in Hepatitis C Virus-Positive Patients: A Study Using Decision Tree Analysis.
- Published in:
- International Journal of Translational Medicine, 2022, v. 2, n. 3, p. 345, doi. 10.3390/ijtm2030027
- By:
- Publication type:
- Article
Effects of antithrombotic drugs on the results of fecal immunochemical test in colorectal neoplasms screening.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-83007-4
- By:
- Publication type:
- Article
Alcohol-associated liver disease increases the risk of muscle loss and mortality in patients with cirrhosis.
- Published in:
- Journal of Gastroenterology, 2024, v. 59, n. 10, p. 932, doi. 10.1007/s00535-024-02137-4
- By:
- Publication type:
- Article
Acute kidney injury development is associated with mortality in Japanese patients with cirrhosis: impact of amino acid imbalance.
- Published in:
- Journal of Gastroenterology, 2024, v. 59, n. 9, p. 849, doi. 10.1007/s00535-024-02126-7
- By:
- Publication type:
- Article
A survey questionnaire evaluating physical activity patterns and determinants in patients with chronic liver disease.
- Published in:
- Journal of Gastroenterology, 2024, v. 59, n. 1, p. 45, doi. 10.1007/s00535-023-02047-x
- By:
- Publication type:
- Article
A shortened Stroop test to identify covert hepatic encephalopathy and predict overt hepatic encephalopathy in patients with cirrhosis.
- Published in:
- Journal of Gastroenterology, 2022, v. 57, n. 12, p. 981, doi. 10.1007/s00535-022-01925-0
- By:
- Publication type:
- Article
Usefulness of nutritional therapy recommended in the Japanese Society of Gastroenterology/Japan Society of Hepatology evidence-based clinical practice guidelines for liver cirrhosis 2020.
- Published in:
- Journal of Gastroenterology, 2021, v. 56, n. 10, p. 928, doi. 10.1007/s00535-021-01821-z
- By:
- Publication type:
- Article
Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma.
- Published in:
- Journal of Gastroenterology, 2015, v. 50, n. 3, p. 323, doi. 10.1007/s00535-014-0964-9
- By:
- Publication type:
- Article
Prevention of Second Primary Tumors by an Acyclic Retinoid in Patients with Hepatocellular Carcinoma.
- Published in:
- Intervirology, 2005, v. 48, n. 1, p. 39, doi. 10.1159/000082093
- By:
- Publication type:
- Article
A simple covert hepatic encephalopathy screening model based on blood biochemical parameters in patients with cirrhosis.
- Published in:
- PLoS ONE, 2022, v. 17, n. 11, p. 1, doi. 10.1371/journal.pone.0277829
- By:
- Publication type:
- Article
FIB‑4 index and NAFLD fibrosis score are useful indicators for screening high‑risk groups of non‑viral hepatocellular carcinoma.
- Published in:
- Molecular & Clinical Oncology, 2023, v. 19, n. 4, p. N.PAG, doi. 10.3892/mco.2023.2676
- By:
- Publication type:
- Article
Development of diffuse large B-cell lymphoma after sofosbuvir-ledipasvir treatment for chronic hepatitis C: A case report and literature review.
- Published in:
- Molecular & Clinical Oncology, 2020, v. 13, n. 3, p. N.PAG, doi. 10.3892/mco.2020.2071
- By:
- Publication type:
- Article
Sustained virological response by direct-acting antivirals reduces the recurrence risk of hepatitis C-related hepatocellular carcinoma after curative treatment.
- Published in:
- Molecular & Clinical Oncology, 2020, v. 12, n. 2, p. 111, doi. 10.3892/mco.2019.1956
- By:
- Publication type:
- Article
Pharmaceutical and nutraceutical approaches for preventing liver carcinogenesis: Chemoprevention of hepatocellular carcinoma using acyclic retinoid and branched-chain amino acids.
- Published in:
- Molecular Nutrition & Food Research, 2014, v. 58, n. 1, p. 124, doi. 10.1002/mnfr.201300538
- By:
- Publication type:
- Article